Senores Pharmaceuticals Ltd (SENORES) — Announcement | 27 August 2026
Senores Pharmaceuticals announced it will attend an investor conference on September 2, 2026 at 11:00 AM IST hosted by Elara Capital in Mumbai, discussing publicly available information without UPSI. The meeting is part of scheduled analyst/institutional investor engagements.
About Senores Pharmaceuticals Ltd (SENORES)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when SENORES files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SENORES — Free💡 Ask AI about this filing
📊 More SENORES filings
- 🟡 Board Meeting — 25 September 2026Senores Pharmaceuticals held its 9th AGM on September 25, 2026 via video conference, adopting audite...
- Announcement — 24 September 2026Senores Pharmaceuticals announced that its trading window will close on October 1, 2026, and remain ...
- Announcement — 21 September 2026Senores Pharmaceuticals clarified that recent trading volume changes are normal market fluctuations ...
- 🔴 Announcement — 11 September 2026Senores Pharmaceuticals announced that its subsidiary Apnar Pharma completed a USFDA inspection at i...
- 🔴 Annual Report — 9 September 2026Senores Pharmaceuticals reported FY 2025-26 revenue of **[amount context mismatch] crores**, up from...
🔥 Also filed on 27 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SENORES files new disclosures
Track SENORES filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SENORES — FreeFree account · 2 AI queries/day